In a research report released on Monday, September 15, 2025, Cantor Fitzgerald reaffirmed its Overweight rating on Archer Aviation Inc. (NYSE:ACHR) with a price objective of $13.00. The company’s ...

University of Maine researchers developed a new process to make HBL, a key ingredient in many medicines, from renewable glucose instead of petroleum. The approach not only lowers drug production costs ...

Did you know you can customize Google to filter out garbage? Take these steps for better search results, including adding Lifehacker as a preferred source for tech news. You may have heard of the ...

With iOS 18, Apple introduced a “Slow Charger” warning for iPhone users looking to diagnose or improve the charging speed of their iPhones. Now, the same warning is coming to watchOS 26. Here’s how to ...

Cantor Jonathan Neil Grant of Orange County, CA, Cantor Emeritus at Temple Bat Yahm in Newport Beach, CA, died at age 66 from complications of ALS. He was at home, lovingly supported by his wife, his ...

A team of University of Saskatchewan (USask) researchers have identified a pathway to help the human body defend itself against sepsis—a life-threatening condition caused by the body's inappropriate ...

Rubrik, Inc. (NYSE:RBRK) is one of the AI Stocks on Wall Street’s Radar. On September 10, Cantor Fitzgerald analyst Jonathan Ruykhaver reiterated an Overweight rating and $115.00 price target the ...

Investing.com - Cantor Fitzgerald has reiterated an Overweight rating on aTyr Pharma (NASDAQ:ATYR) stock, maintaining its positive outlook on the biopharmaceutical company. The stock has shown strong ...

The research also shows that, like any biology student who has struggled with experiment design will know, accurate data is all about getting the methods of testing right. "This study demonstrated the ...

So welcome to the Cantor Global Healthcare Conference. I'm Pete Stavropoulos, a biotech analyst with Cantor. With us, we have Vera Therapeutics, a company I cover, and I'm pleased to introduce ...

All right. Hello, everyone. My name is Prakhar Agrawal. I'm a biotech analyst at Cantor. Welcome to day 1 of Cantor's Global Healthcare Conference. And for the next session, we are very excited to ...